Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AZN AstraZeneca	$73.79 +1.3%	$73.55	$62.75 ▼ $87.68	$228.84B	0.41	5.09 million shs	3.43 million shs
CHKP Check Point Software Technologies	$228.37 -1.3%	$217.58	$145.75 ▼ $238.43	$25.12B	0.62	731,947 shs	941,662 shs
TMUS T-Mobile US	$264.93 -1.2%	$252.92	$159.14 ▼ $276.49	$302.48B	0.64	4.15 million shs	3.32 million shs

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AZN AstraZeneca	0.00%	-1.52%	-3.18%	+12.54%	+8.92%
CHKP Check Point Software Technologies	0.00%	+0.18%	+3.68%	+21.95%	+39.24%
TMUS T-Mobile US	0.00%	+3.55%	-1.76%	+20.06%	+62.31%

Remove Ads

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AZN AstraZeneca	2.9836 of 5 stars	2.6	5.0	1.7	0.0	3.6	0.0	1.3
CHKP Check Point Software Technologies	4.5285 of 5 stars	2.2	5.0	0.0	3.5	3.9	3.3	1.9
TMUS T-Mobile US	4.4451 of 5 stars	2.3	3.0	2.5	3.4	3.0	1.7	2.5

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AZN AstraZeneca	3.10	Buy	$89.75	21.63% Upside
CHKP Check Point Software Technologies	2.48	Hold	$234.18	2.54% Upside
TMUS T-Mobile US	2.61	Moderate Buy	$256.80	-3.07% Downside

Current Analyst Ratings Breakdown

Latest TMUS, AZN, and CHKP Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
3/28/2025	CHKP Check Point Software Technologies	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Market Perform ➝ Outperform	$245.00 ➝ $275.00
3/27/2025	CHKP Check Point Software Technologies	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$230.00 ➝ $260.00
3/27/2025	TMUS T-Mobile US	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$275.00 ➝ $275.00
3/21/2025	TMUS T-Mobile US	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
3/21/2025	TMUS T-Mobile US	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Sector Perform ➝ Sector Perform	$245.00 ➝ $260.00
3/18/2025	CHKP Check Point Software Technologies	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Equal Weight ➝ Equal Weight	$200.00 ➝ $235.00
3/18/2025	TMUS T-Mobile US	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$265.00 ➝ $270.00
3/14/2025	CHKP Check Point Software Technologies	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Equal Weight ➝ Overweight	$200.00 ➝ $280.00
3/14/2025	TMUS T-Mobile US	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$268.00
3/5/2025	TMUS T-Mobile US	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
3/5/2025	TMUS T-Mobile US	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold	$270.00

(Data available from 3/31/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AZN AstraZeneca	$54.07B	4.23	$6.26 per share	11.79	$13.18 per share	5.60
CHKP Check Point Software Technologies	$2.57B	9.79	$9.40 per share	24.29	$25.36 per share	9.01
TMUS T-Mobile US	$81.40B	3.72	$21.21 per share	12.49	$54.08 per share	4.90

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AZN AstraZeneca	$7.04B	$2.26	32.65	14.76	1.42	13.01%	32.23%	12.31%	4/24/2025 (Estimated)
CHKP Check Point Software Technologies	$845.70M	$7.47	30.57	24.12	3.41	32.97%	32.40%	16.26%	4/24/2025 (Estimated)
TMUS T-Mobile US	$11.34B	$9.67	27.40	21.56	1.55	13.93%	18.09%	5.44%	4/24/2025 (Estimated)

Latest TMUS, AZN, and CHKP Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
4/24/2025	N/A	AZN AstraZeneca	$1.10	N/A	N/A	N/A	N/A	N/A
4/24/2025	N/A	CHKP Check Point Software Technologies	$2.19	N/A	N/A	N/A	$635.80 million	N/A
4/24/2025	N/A	TMUS T-Mobile US	$2.48	N/A	N/A	N/A	$20.67 billion	N/A
2/6/2025	Q4 2024	AZN AstraZeneca	$1.10	$1.05	-$0.05	$0.48	$14.19 billion	N/A
1/29/2025	Q4 2024	TMUS T-Mobile US	$2.15	$2.57	+$0.42	$2.57	$21.37 billion	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AZN AstraZeneca	$2.06	2.79%	+1.98%	91.15%	N/A
CHKP Check Point Software Technologies	N/A	N/A	N/A	N/A	N/A
TMUS T-Mobile US	$3.52	1.33%	N/A	36.40%	N/A

Latest TMUS, AZN, and CHKP Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/6/2025	TMUS T-Mobile US	quarterly	$0.88	1.42%	5/30/2025	5/30/2025	6/22/2025
2/6/2025	AZN AstraZeneca	semi-annual	$1.03	2%	2/21/2025	2/21/2025	3/24/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AZN AstraZeneca	0.65	0.93	0.74
CHKP Check Point Software Technologies	N/A	1.13	1.14
TMUS T-Mobile US	1.28	0.91	0.83

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AZN AstraZeneca	20.35%
CHKP Check Point Software Technologies	98.51%
TMUS T-Mobile US	42.49%

Insider Ownership

Company	Insider Ownership
AZN AstraZeneca	N/A
CHKP Check Point Software Technologies	29.00%
TMUS T-Mobile US	0.67%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AZN AstraZeneca	83,500	3.10 billion	N/A	Optionable
CHKP Check Point Software Technologies	5,800	109.98 million	78.09 million	Optionable
TMUS T-Mobile US	71,000	1.14 billion	1.13 billion	Optionable

TMUS, AZN, and CHKP Headlines

Recent News About These Companies

Allstate Corp Acquires New Shares in T-Mobile US, Inc. (NASDAQ:TMUS)

March 31 at 5:11 AM | marketbeat.com

Brown Brothers Harriman & Co. Has $1.71 Million Holdings in T-Mobile US, Inc. (NASDAQ:TMUS)

March 31 at 5:10 AM | marketbeat.com

50,885 Shares in T-Mobile US, Inc. (NASDAQ:TMUS) Bought by Allianz SE

March 30 at 7:19 AM | marketbeat.com

Cornercap Investment Counsel Inc. Sells 1,915 Shares of T-Mobile US, Inc. (NASDAQ:TMUS)

March 30 at 7:07 AM | marketbeat.com

Horizon Investment Services LLC Buys Shares of 14,946 T-Mobile US, Inc. (NASDAQ:TMUS)

March 30 at 6:12 AM | marketbeat.com

Nomura Asset Management Co. Ltd. Cuts Holdings in T-Mobile US, Inc. (NASDAQ:TMUS)

March 30 at 5:36 AM | marketbeat.com

Citi Sticks to Their Hold Rating for T Mobile US (TMUS)

March 30 at 1:44 AM | markets.businessinsider.com

DnB Asset Management AS Sells 187,148 Shares of T-Mobile US, Inc. (NASDAQ:TMUS)

March 29 at 7:18 AM | marketbeat.com

Hoertkorn Richard Charles Has $9.56 Million Stock Position in T-Mobile US, Inc. (NASDAQ:TMUS)

March 29 at 7:16 AM | marketbeat.com

denkapparat Operations GmbH Takes $519,000 Position in T-Mobile US, Inc. (NASDAQ:TMUS)

March 29 at 6:54 AM | marketbeat.com

T-Mobile US, Inc. (NASDAQ:TMUS) Stock Position Trimmed by High Ground Investment Management LLP

March 29 at 6:41 AM | marketbeat.com

Broadway Wealth Solutions Inc. Invests $310,000 in T-Mobile US, Inc. (NASDAQ:TMUS)

March 29 at 6:37 AM | marketbeat.com

New Age Alpha Advisors LLC Buys 57,639 Shares of T-Mobile US, Inc. (NASDAQ:TMUS)

March 29 at 6:24 AM | marketbeat.com

IQ EQ FUND MANAGEMENT IRELAND Ltd Has $1.67 Million Stock Holdings in T-Mobile US, Inc. (NASDAQ:TMUS)

March 29 at 5:47 AM | marketbeat.com

Sava Infond d.o.o. Acquires New Stake in T-Mobile US, Inc. (NASDAQ:TMUS)

March 29 at 5:31 AM | marketbeat.com

T-Mobile US (NASDAQ:TMUS) Receives "Buy" Rating from Benchmark

March 29 at 2:43 AM | americanbankingnews.com

Why T-Mobile US Inc (TMUS) Is Surging In 2025?

March 28 at 3:45 PM | msn.com

Is T-Mobile US Inc. (NASDAQ:TMUS) the Best Telecom Stock to Buy According to Hedge Funds?

March 28 at 1:39 PM | insidermonkey.com

T-Mobile US's (TMUS) "Buy" Rating Reaffirmed at Benchmark

March 28 at 9:56 AM | marketbeat.com

8,165,601 Shares in T-Mobile US, Inc. (NASDAQ:TMUS) Bought by Norges Bank

March 28 at 7:32 AM | marketbeat.com

NEOS Investment Management LLC Grows Position in T-Mobile US, Inc. (NASDAQ:TMUS)

March 28 at 6:40 AM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Warren Buffett Swaps VOO for This Reliable Dividend Stock
By Sarah Horvath | March 7, 2025
View Warren Buffett Swaps VOO for This Reliable Dividend Stock
NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
By Thomas Hughes | March 12, 2025
View NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?
By Jeffrey Neal Johnson | March 21, 2025
View BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?
Archer Aviation Stock Climbs as Midnight eVTOL Nears Reality
By Jeffrey Neal Johnson | March 10, 2025
View Archer Aviation Stock Climbs as Midnight eVTOL Nears Reality
Consumers Are Cutting Back, But These 3 Stocks Will Stay Strong
By Gabriel Osorio-Mazilli | March 17, 2025
View Consumers Are Cutting Back, But These 3 Stocks Will Stay Strong

TMUS, AZN, and CHKP Company Descriptions

AstraZeneca NASDAQ:AZN

$73.79 +0.95 (+1.30%)

Closing price 03/28/2025 04:00 PM Eastern

Extended Trading

$72.92 -0.87 (-1.18%)

As of 03/28/2025 07:51 PM Eastern

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Check Point Software Technologies NASDAQ:CHKP

$228.37 -2.94 (-1.27%)

Closing price 03/28/2025 04:00 PM Eastern

Extended Trading

$228.40 +0.03 (+0.01%)

As of 03/28/2025 07:39 PM Eastern

Check Point Software Technologies Ltd. develops, markets, and supports a range of products and services for IT security worldwide. The company offers a multilevel security architecture, cloud, network, mobile devices, endpoints information, and IOT solutions. It provides Check Point Infinity Architecture, a cyber security architecture that protects against fifth generation cyber-attacks across various networks, endpoint, cloud, workloads, Internet of Things, and mobile. In addition, the company offers security gateways and software platforms that support small and medium sized business. Further, it provides cloud network security, cloud native application protection, security and posture management, cloud identity and entitlement, cloud workload protection, cloud detection and response, and cloud web application protection for web applications and APIs; and Check Point Harmony that delivers endpoint and secure connectivity for remote user access. Additionally, the company offers technical customer support programs and plans; professional services in implementing, upgrading, and optimizing Check Point products comprising design planning and security implementation; and certification and educational training services on Check Point products. It sells its products through distributors, resellers, system integrators, original equipment manufacturers, and managed security service providers. Check Point Software Technologies Ltd. was incorporated in 1993 and is headquartered in Tel Aviv, Israel.

T-Mobile US NASDAQ:TMUS

$264.93 -3.35 (-1.25%)

Closing price 03/28/2025 04:00 PM Eastern

Extended Trading

$263.33 -1.60 (-0.60%)

As of 03/28/2025 08:00 PM Eastern

T-Mobile US, Inc., together with its subsidiaries, provides mobile communications services in the United States, Puerto Rico, and the United States Virgin Islands. The company offers voice, messaging, and data services to customers in the postpaid, prepaid, and wholesale and other services. It also provides wireless devices, including smartphones, wearables, tablets, home broadband routers, and other mobile communication devices, as well as wireless devices and accessories; financing through equipment installment plans; reinsurance for device insurance policies and extended warranty contracts; leasing through JUMP! On Demand; and High Speed Internet services. In addition, the company offers services, devices, and accessories under the T-Mobile and Metro by T-Mobile brands through its owned and operated retail stores, T-Mobile app and customer care channels, and its websites. It also sells its devices to dealers and other third-party distributors for resale through independent third-party retail outlets and various third-party websites. The company was founded in 1994 and is headquartered in Bellevue, Washington.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time